Evaluation of pharmacokinetic parameters of critically ill patients and simulation of dosing regimens required by Bayesian Therapeutic Drug Monitoring of fluconazole

被引：0
|
作者：
Matusik, E. [1 ]
Bienvenu, A. L. [1 ]
Pradat, P. [2 ]
Rimmele, T. [3 ]
Pirriou, V. [4 ]
Gagnieu, M. C. [5 ]
Parent, F. [5 ]
Tod, M. [1 ]
Leboucher, G. [1 ]
Goutelle, S. [1 ]
机构：
[1] Hosp Civils, Groupement Hosp Nord, Serv Pharm Pharmacol, Lyon, France
[2] Univ Lyon, ICBMS CNRS5246, Campus Lyon Tech Doua, Lyon, France
[3] Hosp Civils, Groupement Hosp Sud, Serv Anesthesie Reanimat, Lyon, France
[4] Hosp Civils, Groupement Hosp Ctr, Serv dAnesthesie Reanimat, Lyon, France
[5] Hosp Civils, Groupement Hosp Sud, Lab Biochim & Biol Mol, UM Pharmaco Toxicol, Lyon, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
therapeutic drug monitoring; fluconazole; antifungal agent; pharmacokinetics; invasive candidiasis;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM2-010
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [21] Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
    Roberts, Jason A.
    Ulldemolins, Marta
    Roberts, Michael S.
    McWhinney, Brett
    Ungerer, Jacobus
    Paterson, David L.
    Lipman, Jeffrey
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (04) : 332 - 339
  • [22] Fluconazole: A drug use evaluation and algorithm for use in critically ill patients with candidal infections
    Stein, GE
    Smith, CL
    FORMULARY, 1998, 33 (10) : 1003 - 1006
  • [23] Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
    Li, Xiping
    Liu, Xiaoqin
    Mao, Juehui
    Liu, Dong
    Jiao, Zheng
    PHARMACEUTICS, 2024, 16 (09)
  • [24] Colistin Dosing Regimens against Pseudomonas aeruginosa in Critically Ill Patients: An Application of Monte Carlo Simulation
    Nguyen, Van Thi Khanh
    Montakantikul, Preecha
    Tragulpiankit, Pramote
    Houngsaitong, Jantana
    Shuib, Mohd Fazli
    ANTIBIOTICS-BASEL, 2021, 10 (05):
  • [25] Pharmacokinetic/pharmacodynamic evaluation of tobramycin dosing in critically ill patients: the Hartford nomogram does not fit
    Xie, Feifan
    Wang, Yan
    Peng, Yaru
    Cheng, Zeneng
    Li, Sanwang
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (09) : 2335 - 2341
  • [26] Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
    Sime, Fekade Bruck
    Roberts, Michael S.
    Peake, Sandra L.
    Lipman, Jeffrey
    Roberts, Jason A.
    ANNALS OF INTENSIVE CARE, 2012, 2
  • [27] Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
    Fekade Bruck Sime
    Michael S Roberts
    Sandra L Peake
    Jeffrey Lipman
    Jason A Roberts
    Annals of Intensive Care, 2
  • [28] External Evaluation of Population Pharmacokinetic Models to Inform Precision Dosing of Meropenem in Critically Ill Patients
    Yang, Nan
    Wang, Jing
    Xie, Yueliang
    Ding, Junjie
    Wu, Cuifang
    Liu, Jingjing
    Pei, Qi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] Evaluation of the Accuracy of a Pharmacokinetic Dosing Program in Predicting Serum Vancomycin Concentrations in Critically Ill Patients
    Aubron, Cecile
    Corallo, Carmela E.
    Nunn, Maya O.
    Dooley, Michael J.
    Cheng, Allen C.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (10) : 1193 - 1198
  • [30] Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial Dosing
    Chiriac, Ute
    Richter, Daniel C.
    Frey, Otto R.
    Roehr, Anka C.
    Helbig, Sophia
    Preisenberger, Judit
    Hagel, Stefan
    Roberts, Jason A.
    Weigand, Markus A.
    Brinkmann, Alexander
    ANTIBIOTICS-BASEL, 2021, 10 (06):
12345